Analyst Coverage
The analysts at the investment and securities firms listed below currently write research reports on GW Pharmaceuticals plc. Please note that this list is subject to change and that any estimates, forecasts or opinions are made by the analysts alone and do not represent the estimates, forecasts or opinions of GW or its management. By distributing the information below, GW does not imply its endorsement of or concurrence with such information. GW does not accept any responsibility whatsoever for the views of these or any other analysts reporting on the company.
Edison Investment Research
Robin Davison
Tel: +44 (0)20 3077 5700
Lala Gregorek
Tel: +44 (0)20 3077 5736
http://www.edisoninvestmentresearch.co.uk
- Click here for Edison research – 13.12.11
- Click here for Edison research – 05.07.11
- Click here for Edison research – 23.05.11
- Click here for Edison research – 12.04.11
- Click here for Edison research – 23.03.11
- Click here for Edison research – 30.11.10
- Click here for Edison research – 13.10.10
- Click here for Edison research – 03.06.10
- Click here for Edison research – 25.03.10
- Click here for Edison research – 19.03.10
- Click here for Edison research – 26.11.09
Edison's GW company profile page : http://www.edisoninvestmentresearch.co.uk/research/company/GW-Pharmaceuticals
(access requires free registration)
Peel Hunt
Paul Cuddon
Stefan Hamill
Tel: +44 (0)20 7418 8900
Nomura Code Securities
Samir Devani
Tel: +44 (0) 207 776 1244
Rodman & Renshaw
Elemer Piros
Tel: +1 212-430-1754
http://www.rodmanandrenshaw.com/
Singer Capital Markets Limited
Shawn Manning
Tel: +44 (0) 20 3205 7500